Professor Bart De Strooper (UK Dementia Research Institute at UCL) has been awarded an honorary CBE for his services to ...

Science minister Sir Patrick Vallance said he was "super excited" by advancements in dementia diagnosis and treatment ...

Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and lecanemab, were rejected by the Scottish Medicines Consortium (SMC), ...

Patients in Wales could be some of the first to benefit new research looking at how Artificial Intelligence combined with ...

Alzheimer’s Research UK said the new study “adds to the growing evidence that repairing the blood-brain barrier (BBB) itself could offer a new way to treat Alzheimer’s,” but added that it is too early ...

From blood tests to AI, new ways to diagnose dementia sooner and treat it faster set to be unlocked by new research challenge. From blood tests to ...

Researchers have discovered that problems with the brain’s waste-clearing system—the glymphatic system—may significantly ...

Regulatory authorities in the UK are being urged to speed their review of lecanemab (Leqembi, Eisai) after the US Food and Drug Administration (FDA) approved it for early-stage Alzheimer's disease.

University College London has published a study, part funded by Alzheimer’s Society’s Heather Corrie Impact Fund, which shows ...

A new MoU fosters collaboration between leading institutes to explore diabetes' impact on brain health and cognitive decline.

Seven days of festive Black Friday offers gets underway at the Christmas Shopping Night event, from 5pm to 8pm.